Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer

• Status: Terminated
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this clinical research study is to learn if BMS-275183 can shrink or slow the growth of the cancer in subjects with non-small cell lung cancer (NSCLC). The safety of this treatment will also be studied.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bristol-Myers Squibb

Criteria

Inclusion Criteria:

• Advanced or metastatic pretreated NSCLC

• Measurable disease

• Adequate hematologic, hepatic and renal functions

• ECOG Performance Status of 0-2

Exclusion Criteria:

• Inability to swallow capsules

• Recent significant cardiovascular disease

• Woman who are pregnant or breastfeeding